# Ropivacaine Use Intraincisionally Versus Intraperitoneally for Post-Laparoscopic Cholecystectomy Pain

> **NCT03265223** · PHASE4 · COMPLETED · sponsor: **Jawaharlal Nehru Medical College** · enrollment: 353 (actual)

## Conditions studied

- Ropivacaine
- Laparoscopic Cholecystectomy
- Pain

## Interventions

- **DRUG:** 0.2% ropivacaine

## Key facts

- **NCT ID:** NCT03265223
- **Lead sponsor:** Jawaharlal Nehru Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-01
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-08-15
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2017-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03265223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03265223, "Ropivacaine Use Intraincisionally Versus Intraperitoneally for Post-Laparoscopic Cholecystectomy Pain". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03265223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*